| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |